@symbiotica avatar
Follow Send message
@symbiotica

Symbiotica Therapeutics

Innovator•Italy

Investment
4Following 9Followers

Health•Seed

Symbiotica Therapeutics has developed a proprietary therapeutic delivery platform that enables the sustained release of therapeutic proteins and peptides directly within the patient’s body. The technology is based on biocompatible symbiotic particles which, following a single subcutaneous injection, remain localized at the injection site and provide stable, long-term release of the active compound over time, similarly to a “therapeutic tattoo”, thereby improving the efficacy and safety profile of biologic therapies. The active compound reaches the bloodstream and exerts its therapeutic function on the target tissues. This approach overcomes the limitations of current solutions, which require frequent administrations and are often associated with side effects and high costs. Continuous delivery allows for maintaining low but steady therapeutic levels, reducing toxicity and improving patient adherence. The platform has already achieved in vivo proof of concept, demonstrating excellent results in terms of efficacy, duration of effect, and safety. The project is protected by a filed patent, with international extension planned, and has been selected for a competitive grant from a European innovation agency (SPRIND) to support preclinical efficacy studies within a clinically oriented IND-enabling regulatory pathway.

https://www.symbioticatherapeutics.org/
Posts
People
Symbiotica Therapeutics
Health • Italy
🚀 We’re excited to join the Inspired Community with Symbiotica Therapeutics! At Symbiotica Therapeutics, we are developing a new paradigm for biologic drug delivery. Our proprietary platform enables the long-term release of therapeutic proteins and peptides from a single subcutaneous administration, reducing the need for frequent injections and improving both safety and patient adherence. We often describe it as a “therapeutic tattoo”: once administered, the system remains localized and continuously delivers low, steady therapeutic doses into the bloodstream. This approach addresses some of the biggest challenges in modern biologic therapies: short half-life, side effects, high costs, and poor adherence and it opens the door to more effective treatments for chronic and high-impact diseases. 🔬 What we’ve achieved so far - In vivo proof of concept with strong efficacy, durability, and safety - Patent filed, with international extension planned - Selection for a competitive European innovation grant (SPRIND) supporting IND-enabling preclinical studies - A multidisciplinary, international team combining scientific, clinical, regulatory, and entrepreneurial expertise 💡 Why your vote matters The Inspired Contest is a powerful way to support early, science-driven innovation. Every vote helps us gain visibility, build momentum, and accelerate the path toward clinical impact. 👉 If you believe in long-term, patient-friendly therapies and breakthrough biotech innovation, we’d be grateful for your vote! Thank you for supporting Symbiotica Therapeutics!!
Investment

Connect with Symbiotica Therapeutics

Join Inspired